Corpus Intelligence IC Memo — MONTROSE MEMORIAL HOSPITAL 2026-04-26 09:38 UTC
IC Memo — MONTROSE MEMORIAL HOSPITAL
Investment Committee Memorandum | CO | 47 beds | Grade C | EBITDA uplift $10.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MONTROSE MEMORIAL HOSPITAL

CCN 060006 | MONTROSE, CO | 47 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

MONTROSE MEMORIAL HOSPITAL is a 47-bed suburban community hospital in MONTROSE, CO with $147.2M in net patient revenue and a -0.7% operating margin. The hospital serves a payer mix of 32.7% Medicare, 6.9% Medicaid, and 60.4% commercial.

Thesis: Turnaround. Our ML models identify $10.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -0.7% to 6.6% (+736bps).

Net Revenue HCRIS$147.2M
Current EBITDA COMPUTED$-1.1M
Operating Margin COMPUTED-0.7%
Occupancy HCRIS40.7%
Revenue / Bed COMPUTED$3.1M
Net-to-Gross HCRIS35.2%
Distress Probability ML48.8%

2. Market Context & Competitive Position

108
CO Hospitals
-3.6%
State Median Margin
50
Comparable Hospitals

CO has 108 Medicare-certified hospitals with a median operating margin of -3.6%. The target's margin of -0.7% places it above the state median. Among 50 size-comparable peers (24-94 beds), the median margin is -4.6%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (24-94), prioritizing same-state peers. 50 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MONTROSE MEMORIAL HOSPITAL (Target)CO47$147.2M-0.7%
VALLEY VIEW HOSPITALCO31$285.3M-3.1%
CENTURA MERCY HOSPITALCO73$270.4M10.0%
UCHEALTH HIGHLANDS RANCH HOSPICO93$235.2M-4.6%
COMMUNITY HOSPITALCO44$216.5M-5.5%
VAIL VALLEY MEDICAL CENTERCO54$214.4M-28.1%
UCHEALTH LONGS PEAK HOSPITALCO83$181.8M-1.7%
PLATTE VALLEY MEDICAL CENTERCO89$181.0M-12.3%
CENTURA CASTLE ROCK ADVENTIST CO89$171.0M8.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $10.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$3.1M+210bp18mo
Cost to Collect4.5%2.5%$2.9M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.9M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.8M+122bp9mo
Clean Claim Rate88.0%96.0%$94K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$3.1M
Cost to Collect
$2.9M
Denial Rate Reduction
$2.9M
A/R Days Reduction
$1.8M
Clean Claim Rate
$94K
Total EBITDA Uplift$10.8M
Current EBITDA$-1.1M
+ RCM Uplift+$10.8M
Pro Forma EBITDA$9.7M
Current Margin-0.7%
Pro Forma Margin6.6%
WC Released (1x)$5.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-1.7M$101.1M0.00x-100.0%
Base (11x exit)10.0x11.0x$-1.7M$110.6M0.00x-100.0%
Bull Case9.0x11.0x$-1.5M$145.8M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-1.5M$158.6M0.00x-100.0%
Bear Case11.0x10.0x$-1.9M$47.5M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-1.9M$51.6M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 50 hospitals with 24-94 beds
  • Same-state prioritization (n=51)
  • Comp margins: P25=-9.7% / P50=-4.6% / P75=3.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.